Nanox ' s stock falters after investor report calls its business ' a complete farce '

Activist short seller Citron Research called  the Israeli digital X-ray company out on its limited R&D expenditure,  suspicious distribution agreements and other factors. Nanox has described the report as incorrect and misleading.
Source: mobihealthnews - Category: Information Technology Source Type: news